ifuse
-
Spine
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
SANTA CLARA, Calif., June 13, 2022 (GLOBE NEWSWIRE) — SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Regulatory
SI-BONE, Inc. Announces that Humana Establishes Exclusive Coverage for iFuse in MIS SI Joint Fusion Procedures
SANTA CLARA, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated…
Read More » -
OSN Premium
SI-BONE, Inc. Announces Wellmark Blue Cross Blue Shield Establishes Positive Coverage for MIS SI Joint Fusion Using iFuse
SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Spine
SI-BONE’s iFuse Implant System® Requires Revision Surgery 5 Times Less Compared to SI Joint Fixation with Screws According to New Peer-Reviewed Clinical Publication
SAN JOSE, Calif., Jan. 23, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse…
Read More » -
Spine
SI-BONE, Inc. Announces iFuse Implant System® Warranty Program in Support of Patients, Providers and Payors
SAN JOSE, Calif., Jan. 9, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant…
Read More » -
Spine
Health Care Service Corporation (HCSC), the Fourth Largest Health Insurer in the United States, Establishes Exclusive Positive Coverage Policy for SI-BONE’s iFuse Implant System® for Minimally Invasive Sacroiliac Joint Fusion
SAN JOSE, Calif., Dec. 15, 2016 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant…
Read More » -
Financial
SI-BONE, Inc. Announces SelectHealth of Utah to Cover Minimally Invasive Sacroiliac Joint Fusion Exclusively Using the iFuse Implant System® as the Only Proven Technology
SAN JOSE, Calif., Oct. 27, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System…
Read More » -
Spine
SI-BONE, Inc. Announces Two-Year Results from a Randomized Controlled Trial of the iFuse Implant System® vs. Non-Surgical Management for Some Causes of Sacroiliac Joint Dysfunction
SAN JOSE, Calif., Aug. 24, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Spine
SI-BONE, Inc. Announces 40th Peer-Reviewed Publication – a Multicenter Long Term Outcomes Study Showing Durable Results With the iFuse Implant System®
SAN JOSE, Calif., July 18, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Spine
Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System® for SI Joint Fusion
SAN JOSE, Calif., June 15, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Hospitals
SI-BONE, Inc. Announces 510(k) Clearance for Updated Indication for the iFuse Implant System®
SAN JOSE, Calif., June 13, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of Two-Year Results From a Prospective Multicenter Clinical Trial Showing Long-Term Clinical Benefits from SI Joint Fusion with the iFuse Implant System
SAN JOSE, Calif., April 20, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More » -
Blue Cross Blue Shield of Michigan Announces Positive Coverage Policy for iFuse Implant System® MIS SI Joint Fusion
SAN JOSE, Calif., March 21, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More »